Azra AI is a prominent player in the field of health technology, employing the capabilities of artificial intelligence and workflow automation to expedite the detection and treatment of cancer. We're thrilled to introduce SmartPath™, our groundbreaking AI-driven solution tailored to provide crucial support to tumor registry teams operating in hospitals and healthcare facilities nationwide.Given recent disruptions in the reporting of registry data from all participating states in the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program, SmartPath emerges as a dependable solution to ensure uninterrupted operations.

Streamlined Workflow: SmartPath offers a seamless end-to-end automated workflow that significantly reduces the need for manual intervention. Hospitals can anticipate a notable improvement in efficiency and speed in tumor registry operations with SmartPath. Tasks that previously required hours or days can now be completed in a fraction of the time, allowing healthcare professionals to allocate their time and resources more effectively.

SmartPath features an intuitive and user-friendly interface that necessitates minimal training. Your tumor registry teams can swiftly adapt to this cutting-edge solution without extensive IT support.Ensure effortless compliance with regulatory requirements through SmartPath's built-in reporting capabilities. This ensures a smooth transition with minimal disruption to your existing workflows.

Patient data security is a paramount concern. SmartPath employs robust security measures to protect patient information, fully complying with all relevant healthcare data privacy regulations. By adopting SmartPath, hospitals can enhance the quality of cancer data collection and, in turn, improve the overall patient care experience.

Source: businesswire.com